Holen Sie sich die Stockscreener-App
11.15
0.50%
0.055
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$11.10
Offen:
$11.05
24-Stunden-Volumen:
2.55M
Relative Volume:
0.74
Marktkapitalisierung:
$2.23B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-5.3889
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
+0.41%
1M Leistung:
-0.22%
6M Leistung:
-31.25%
1J Leistung:
-42.65%
1-Tages-Spanne:
$11.05
$11.28
1-Wochen-Bereich:
$11.03
$11.44
52-Wochen-Spanne:
$9.85
$20.59
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
11.15 | 2.22B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
560.79 | 200.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
189.15 | 54.09B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.97 | 38.74B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
246.74 | 36.50B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
266.88 | 19.36B | 2.96B | 487.70M | 344.00M | 6.6758 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Barclays Initiates Coverage on Dentsply Sirona (XRAY) with Under - GuruFocus
U.S. Dental Prosthetics Market Intelligence Report 2025-2033 Featuring Dentsply Sirona, 3D Systems, Solventum, Ivoclar Vivadent, Institut Straumann and MoreResearchAndMarkets.com - Business Wire
How Investors Are Reacting To DENTSPLY SIRONA (XRAY) Appointing an Interim CFO With Turnaround Expertise - simplywall.st
Norges Bank Purchases New Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Evaluating the Accuracy of Two Intraoral Scanning Systems in Reproducing Implant Positions for Prosthetic Fabrication: A Cross-Sectional Comparative Study - Cureus
Custom Nightguards Initiated in Dentrix Now Available from Henry Schein - Dentistry Today
DENTSPLY SIRONA Inc. $XRAY Shares Sold by Quantbot Technologies LP - MarketBeat
Landmark study underscores efficacy of Reciproc endodontic system - Dental Tribune US
How dovish Fed policy supports DENTSPLY SIRONA Inc. (DY2) stock2025 Volatility Report & Daily Profit Maximizing Tips - Newser
Will DENTSPLY SIRONA Inc. (DY2) stock maintain strong growthMarket Risk Report & Free High Accuracy Swing Entry Alerts - Newser
Why DENTSPLY SIRONA Inc. (DY2) stock is a strong analyst pickMarket Risk Summary & Growth Focused Investment Plans - Newser
Intraoral Scanners Market Is Going to Boom | Align Technology • - openPR.com
South Korea Dental Anesthesia Market Toward USD 80.5 Billion - openPR.com
Can DENTSPLY SIRONA Inc. stock deliver sustainable ROE2025 Momentum Check & Smart Swing Trading Techniques - Newser
DENTSPLY SIRONA Inc. (XRAY) Stock Forecasts - Yahoo Finance
Dentsply Sirona: Advancing Endodontics through Evidence, Quality, and Innovation - marketscreener.com
Why DENTSPLY SIRONA Inc. (DY2) stock could outperform next yearPortfolio Return Report & Long-Term Safe Investment Ideas - Newser
Manufacturer signs lease renewal in Waltham through 2032 - The Business Journals
Brandes Investment Partners LP Has $5.98 Million Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Sirona Q3 2025 Earnings Preview - MSN
Can Dentsply Sirona Stock Recover If Markets Fall? - Trefis
Why DENTSPLY SIRONA Inc. stock remains resilientDollar Strength & Free Real-Time Market Sentiment Alerts - Newser
U.S. Dental Equipment Market Projections 2025-2032: Key - openPR.com
Is DENTSPLY SIRONA Inc. (DY2) stock considered safe haven2025 Breakouts & Breakdowns & Technical Confirmation Alerts - Newser
Dentsply Sirona Renews Full-Building Lease in Waltham - Connect CRE
VP Johnson Surrenders 9,030 Of Dentsply Sirona Inc [XRAY] - TradingView
DENTSPLY SIRONA Named Top Dividend Stock With Insider Buying and 5.64% Yield (XRAY) - Nasdaq
Dental Caries Detectors Market Set for Dynamic Growth with Key Players Dentsply Sirona, KaVo Kerr, 3M Company - EIN News
Rotary Niti Endodontic Files Market Is Booming So Rapidly: Dentsply Sirona • Mani Inc. • Komet Dental • VDW GmbH - openPR.com
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
With Dentsply Sirona Stock Sliding, Have You Assessed The Risk? - Trefis
Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & G - The National Law Review
Will DENTSPLY SIRONA’s (XRAY) Interim CFO Appointment Signal a Shift in Financial Strategy? - simplywall.st
What drives DENTSPLY SIRONA Inc DY2 stock pricePrice-to-Earnings Ratio Insights & High Profit Market Growth - earlytimes.in
MACD Signals Flash Warning for JFL Life Sciences Limited StockMarket Rumors and News & Low Cost Capital Growth - earlytimes.in
Prudential Financial Inc. Purchases 468,415 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Advisors Asset Management Inc. Purchases 140,129 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Entropy Technologies LP Lowers Stock Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Creative Planning Increases Stock Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DS World: “Creating space for networking and debate" - Dental Tribune US
Dentsply Sirona outlines $3.6B-$3.7B 2025 sales target and accelerated R&D investments amid leadership changes - MSN
DENTSPLY SIRONA Inc. (XRAY) Stock forecasts - Yahoo Finance UK
DENTSPLY SIRONA Appoints Interim CFO Michael Pomeroy - The Globe and Mail
Dentsply Sirona ticks up after interim CFO appointment - MSN
CFOs On the Move: Week ending Nov. 26 - CFO.com
How DENTSPLY SIRONA Inc. stock benefits from strong dollarTrade Entry Report & Low Risk High Win Rate Stock Picks - BỘ NỘI VỤ
Geode Capital Management LLC Sells 119,531 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
U.S. Dental Implants and Abutment Systems Market, 2034 - Global Market Insights Inc.
Edmond DE Rothschild Holding S.A. Raises Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Impressions from DS World Birmingham - Dental Tribune US
North America Dental Implants and Abutment Systems Market, 2034 Report - Global Market Insights Inc.
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
2.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):